Estrid Høgdall

Estrid Høgdall, Clinical professor in Molecular Pathology at University of Copenhagen and Head of Molecular Unit, Department of Pathology

Clinical professor in molecular pathology at University of Copenhagen and Head of Molecular Unit, Department of Pathology, which I established in 2010. Furthermore I am director og Bio –and GenomeBank Denmark which include Danish CancerBiobank (DCB), Danish ReumaBiobank (DRB) and Danish BlooddonorBiobank (DBB). I am responsible for the management, guideline description and programming of the database module. This leadership was a natural continuation of my position as head of the Gynecologic Cancer biobank group.  More nationwide biobanks are planned with me as Director of the Secretry placed at Department of Pathology, Herlev Hospital. The biobanks are founded by Danish Regions.

Career track records are documented in the areas: Molecular pathology, biobanking and various tumor profiling expression analyses. I have been primary investigator in several research studies. Special focus and experience in biomarkers of colorectal and ovarian tumors. Together with top international researchers I have established the Ovarian Tumor Tissue Analysis (OTTA) Consortium, which consists of 30 studies including more than 8,000 ovarian cancer tissue samples.

In the COGCs project – 7.th framework program – I was coordinating the ovarian cancer activity in the Workpackage 6. In hematology an international collaboration with Sandeep Dave at Duke University, North Carolina, is started based on results established in a research study initiated from Department of Pathology, Herlev Hospital.

In addition, I am attending Global Excellence through Department of Gynaecology and Oncology at Rigshospitalet with MD Anderson, Professor R. Bast. In this collaboration Molecular Unit will be partner and perform TMAs and different molecular analyses on sample material from both sites. As a part of Mermaid III the Molecular Unit performs methylations studies, miR studies and sequencing studies on tissue and blood samples from women diagnosed with ovarian tumors.